IL10 and Alzheimer disease: Our meta-analysis demonstrated that both AD-MSCs and bMSCs were effective in mitigating IFN-γ expression and enhancing IL10 levels in the decidual tissue of URSA mice, thereby serving a multi-faceted immunomodulatory role in URSA.